Corcept Therapeutics Incorporated (CORT)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Receivables turnover		11.26	12.53	12.91	12.30	12.23	13.12	13.13	13.49	12.61	12.64	11.82	14.23	12.87	15.11	14.68	11.93	15.38	12.74	13.57	13.45
DSO	days	32.40	29.14	28.26	29.69	29.84	27.83	27.81	27.05	28.95	28.87	30.87	25.65	28.36	24.15	24.86	30.61	23.73	28.65	26.89	27.14

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 11.26
= 32.40

To analyze Corcept Therapeutics Inc's Days Sales Outstanding (DSO) over the past eight quarters, we calculate the average DSO for each quarter. By averaging the DSO figures for a more extended period, we can obtain a more stable and accurate representation of the company's collection efficiency.

The average DSO for Corcept Therapeutics Inc over the past eight quarters is 27.67 days. This metric indicates that, on average, the company takes approximately 27.67 days to collect its accounts receivable. A lower DSO value is often preferred as it signifies that the company is collecting payments from its customers more quickly.

Looking at the trend in DSO over the past eight quarters, we observe slight fluctuations, with some quarters showing a slight increase or decrease compared to the previous period. However, these variations seem relatively minor, indicating that the company's collection efficiency has been relatively consistent over the analyzed period.

In conclusion, Corcept Therapeutics Inc's DSO of 27.67 days suggests a relatively efficient accounts receivable management process. By monitoring this ratio over time, the company can continue to assess and improve its collections practices to maintain a healthy cash flow position.